GoldBamboo.com - Knowledge is strong medicine
  

Incidence/Magnitude-Haemorrhagic Progression-Cerebral Contusions and Identification (ID) of Safety Issues After Traumatic Brain Injury - Article


  Not Signed In - Sign In / Register


Get Your Free Credit Report Right Now!

Zip Code:



General Topics A-Z

Brain Injury

 



Clinical Trial: Incidence/Magnitude-Haemorrhagic Progression-Cerebral Contusions and Identification (ID) of Safety Issues After Traumatic Brain Injury

This study is currently recruiting patients.
Verified by Novo Nordisk July 2005

Sponsored by: Novo Nordisk
Information provided by: Novo Nordisk
ClinicalTrials.gov Identifier: NCT00124293

Purpose

The purpose of this study is to evaluate the occurrence and severity of bleeding in brain injury and to identify important safety issues following traumatic brain injury.
Condition
Traumatic Brain Injury

MedlinePlus related topics:  Head and Brain Injuries

Study Type: Observational
Study Design: Natural History, Cross-Sectional, Defined Population, Prospective Study

Official Title: A Multi Centre Observational Study to Evaluate the Incidence and Magnitude of Haemorrhagic Progression of Cerebral Contusions and the Identification of Important Safety Issues Following Traumatic Brain Injury

Further Study Details: 

Expected Total Enrollment:  100

Study start: October 2004

Eligibility

Ages Eligible for Study:  18 Years   -   85 Years,  Genders Eligible for Study:  Both
Criteria
Ages Eligible for Study: 18 Years - 85 Years

Location and Contact Information

Please refer to this study by ClinicalTrials.gov identifier  NCT00124293

Novo Nordisk Clinical Trial Call Center      866-867-7178 

Arizona
      Theodore, Phoenix,  Arizona,  85013,  United States; Recruiting

California
      Duong, Los Angeles,  California,  90059,  United States; Recruiting

Colorado
      Levy, Denver,  Colorado,  80204,  United States; Recruiting

Delaware
      Fulda, Newark,  Delaware,  19718,  United States; Recruiting

District of Columbia
      Wang, Washington,  District of Columbia,  20010,  United States; Recruiting

Iowa
      Hitchon, Iowa City,  Iowa,  52242,  United States; Recruiting

Maryland
      Dutton, Baltimore,  Maryland,  21201,  United States; Recruiting

Massachusetts
      Badjatia, Boston,  Massachusetts,  02114,  United States; Recruiting

Missouri
      Smith, St. Louis,  Missouri,  63110,  United States; Recruiting

New Jersey
      Sifri, Newark,  New Jersey,  07103,  United States; Recruiting

New York
      O''''Neill, Brooklyn,  New York,  11203,  United States; Recruiting

North Carolina
      Dyer, Charlotte,  North Carolina,  28207,  United States; Recruiting

Ohio
      McCarthy, Dayton,  Ohio,  45409,  United States; Recruiting

      Narayan, Cincinnati,  Ohio,  45219,  United States; Recruiting

Pennsylvania
      Cipolle, Allentown,  Pennsylvania,  18103,  United States; Recruiting

      Grady, Philadelphia,  Pennsylvania,  19104,  United States; Recruiting

      Wilberger, Pittsburgh,  Pennsylvania,  15212-4772,  United States; Recruiting

Tennessee
      Morris, Nashville,  Tennessee,  37212,  United States; Recruiting

Virginia
      Ward, Richmond,  Virginia,  23219,  United States; Recruiting

Canada, Alberta
      Rowe, Edmonton,  Alberta,  T6G 2B7,  Canada; Recruiting

      Zygun, Calgary,  Alberta,  T2N 2T9,  Canada; Recruiting

Canada, British Columbia
      Fenwick, Vancouver,  British Columbia,  V5Z 1M9,  Canada; Recruiting

Canada, Manitoba
      Kaufmann, Winnipeg,  Manitoba,  R3A 1R9,  Canada; Recruiting

Canada, Ontario
      Chapman, Toronto,  Ontario,  M4N 3M5,  Canada; Recruiting

      Cusimano, Toronto,  Ontario,  M5B 1W8,  Canada; Recruiting

      Pagliarello, Ottawa,  Ontario,  K1Y 4E9,  Canada; Recruiting

      Reddy, Hamilton,  Ontario,  L8L 2X2,  Canada; Recruiting

Canada, Quebec
      Albert, Montreal,  Quebec,  H4J 1C5,  Canada; Recruiting

      Evans, Montreal,  Quebec,  H3G 1A4,  Canada; Recruiting

      Poirier, Greenfield Park,  Quebec,  J4V 2H1,  Canada; Recruiting

Study chairs or principal investigators

Brett Skolnick, PhD,  Study Director,  Novo Nordisk   

More Information

Study ID Numbers:  F7CBI-1587
Last Updated:  August 1, 2005
Record first received:  July 26, 2005
ClinicalTrials.gov Identifier:  NCT00124293
Health Authority: United States: Institutional Review Board
ClinicalTrials.gov processed this record on 2005-08-02


Source: ClinicalTrials.gov
Cache Date: August 3, 2005

Resources



[ Disclaimer: The information on GoldBamboo for any particular treatment, medicine, drug, or herbal product might be missing or incomplete, and should never be used as a single source of knowledge. GoldBamboo generally has links to authoritative sites displayed toward the bottom of each topic page under the heading "Resources". ]

Take control over your directory listings...INSTANTLY

Every day, thousands of users find businesses like yours in the GoldBamboo directory.

Limited Time Offer!!!

For only $30 a year, a savings of 70% off our standard rate:

  • Edit your listing (whenever you want!)
  • Link to your website
  • Choose which categories you are listed in
  • Describe your services

The process will take only a few minutes and consists of 3 easy steps:

1. Register     >     2. Edit Listings     >     3. Publish

Your Company
your street
yourtown, YS 12345
888-888-8888



No Thanks

Popular Treatments

Acne Treatment ADHD Treatment Allergy Treatment Alzheimer's Treatment
Anemia Treatment Arthritis Treatment Asthma Treatment Bipolar Disorder Treatment
Bird Flu Treatment Bladder Cancer Treatment Bladder Control Treatment Blood Pressure Treatment
Brain Tumor Treatment Breast Cancer Treatment Bronchitis Treatment Cancer Treatment
Cancer Alternative Treatment Cataract Treatment Cirrhosis Treatment Colitis Treatment
Colon Cancer Treatment Common Cold Treatment Conjunctivitis Treatment Constipation Treatment
Crohn's Disease Treatment Cystic Fibrosis Treatment Depression Treatment Dermatitis Treatment
Diabetes Treatment Edema Treatment Epilepsy Treatment Erectile Dysfunction Treatment
Fibromyalgia Treatment GERD Treatment Glaucoma Treatment Gout Treatment
Hay Fever Treatment Headache Treatment Heart Disease Treatment Hepatitis Treatment
High Blood Pressure Treatment High Cholesterol Treatment Hives Treatment Hypertension Treatment
Hypoglycemia Treatment IBS Treatment Impotence Treatment Indigestion Treatment
Infertility Treatment Influenza Treatment Insomnia Treatment Lactose Intolerance Treatment
Leukemia Treatment Lung Cancer Treatment Lyme Disease Treatment Macular Degeneration Treatment
Menopause Treatment Migraine Treatment Osteoarthritis Treatment Osteoporosis Treatment
Pancreatic Cancer Treatment PMS Treatment Pneumonia Treatment Prostate Diseases Treatment
Restless Leg Treatment Rheumatoid Arthritis Treatment Sepsis Treatment Sinusitis Treatment
Skin Cancer Treatment Sleep Apnea Treatment Snoring Treatment Stroke Treatment
Testicular Cancer Treatment
GoldBambooTM

Your Integrative Health and Wellness Resource for Brain Injury.

December 4, 2009


Page Updated: October 3, 2005
============== Advertisement ==============
Disclaimer: All material displayed on the GoldBamboo.com website is provided for educational purposes only. Consult a physician regarding the applicability of any information found on GoldBamboo.com to your symptoms or medical condition.

Home | About Us | Link To Us | Feedback | Disclaimer | Privacy Policy | Terms of Use | Health Forums

Copyright © 2004-2009 - Anaconda Partners LLC - All rights reserved.

HONcode accreditation seal.

We comply with the HONcode standard for health trust worthy information:
verify here.